US 11215617
Treatment of metastatic prostate cancer
granted A61KA61K31/277A61K31/337
Quick answer
US patent 11215617 (Treatment of metastatic prostate cancer) held by The Regents of the University of California expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/277, A61K31/337, A61K31/405, A61K31/4166